ArticleFrontiers in public health2025
Multidrug-resistant bacterial infections and their clinical impact at the University Teaching Hospital of Kigali in Rwanda: a retrospective descriptive-analytical study.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Multidrug-resistant (MDR) bacterial infections pose a serious global health threat, particularly in low-resource settings where empirical antimicrobial use is common, while associated with poor outcomes and increased resistance. This study evaluated the prevalence, resistance profiles, clinical impact, and treatment options for MDR bacterial infections at the University Teaching Hospital of Kigali, Rwanda. Methods: A retrospective descriptive-analytical study reviewed patient records and microbiology logbooks for culture-confirmed MDR infections from 1 Results: Out of 1,676 positive cultures, 368 (22%) were MDR cases, mostly from surgical patients (30.4%). Urine samples yielded the majority of MDR isolates (52.2%), with Conclusion: MDR bacterial infections were prevalent with longer hospital stays and poor outcomes. Despite high resistance to common antibiotics, amikacin, vancomycin, imipenem, and polymyxin B were effective treatment options. Continuous surveillance, antimicrobial stewardship, and treatment guideline development are crucial. Discussion: The global rise in antimicrobial resistance is a major public health threat requiring local surveillance for targeted interventions and guideline creation. This study at the University Teaching Hospital of Kigali found a 21.9% prevalence of MDR infections, reflecting global trends. Strengthening infection prevention and control and antimicrobial stewardship programs is needed to break transmission chains and optimize antimicrobial use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.